Jeffrey Hyams, MD: Reacting to the Linaclotide Approval for

The US Food and Drug Administration (FDA) approved linaclotide earlier this month for the treatment of patients with functional constipation aged 6-17 years.

Related Keywords

Connecticut , United States , Jeffrey Hyams , Division Head Of Gastroenterology , Drug Administration , Division Head , Connecticut Children ,